Please assess the completion status of the following clinical trial:

Trial Title: Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Self described Asian, first or second generation~* Male or female \> or = 18 years with primary hypercholesterolaemia.~Exclusion Criteria:~* Use of cholesterol lowering drugs from visit 1~* Homozygous familial hypercholesterolaemia~* Active arterial disease within 3 months of study entry~* Poorly controlled diabetes~* Uncontrolled hypothyroidism~* Active liver disease~* History of alcoh/drug abuse.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- rosuvastatin (Type: ACTIVE_COMPARATOR): rosuvastatin 5 mg
- atorvastatin (Type: ACTIVE_COMPARATOR): atorvastatin 10 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).